baber/WOPTO huggingface dataset:
Patent NZ-235733-A (NZ)
Title: Encapsulating spring units between a pair of webs: mattress made from a series of such units
Inventor: RODGERS PAUL
IPC: B65B9/02
Filed: 1990-10-17
Abstract: A method of encapsulating spring units is disclosed. The method comprises inserting an uncompressed spring unit into an insertion device, moving the insertion device between a pair of webs, tightening or tensioning the webs around the insertion device, compressing the spring unit, tightening the webs around the compressed spring unit, withdrawing the insertion device as the webs are tightened, and, while the spring unit is compressed, connecting the webs together.
Patent NZ-240522-A (NZ)
Title: Viterbi algorithm processor includes operator dedicated to parameter determination
Inventor: DESPERBEN LYDIE
IPC: H03M13/23
Filed: 1991-11-08
Abstract: The present invention relates to a device provided in particular for performing the processing of the Viterbi algorithm. The Viterbi algorithm is defined by its constraint length of value n + 1 and its 2<n> states associated with bit strings, the processing having the object of estimating an initial string of bits b(i), from a transmitted string resulting from a transmission operation performed on the initial string. The device comprises a processor and an operator provided to establish the maximum metric of order r of the state Ej, called Metr(Ej), for r greater than n, and the (r-n)nth bit of the string corresponding to this metric, from input values which are the maximum metrics of order r-1 of the states E2k and E2k+1, denoted Metr-1(E2k) and Metr-1(E2k+1), and the conditional probabilities in respect of the said states E2k, E2k+1 of the rth bit of the strings associated with these states having a specified value, called Pr(b(r) = O/E2k) and Pr(b(r) = O/E2k+1) for example, k being equal to 2j for all j less than 2<n-1> and equalling 2(j-2<n-1>) for all j greater than or equal to 2<n-1>, so that Metr(Ej) takes the value of the larger of the two following expressions, the first being Metr-1(E2k) + Pr(b(r) = O/E2k) and the second being Metr-1(E2k+1) + Pr(b(r) = O/E2k+1). <IMAGE>
Patent NZ-244426-A (NZ)
Title: Absorbent article - side gaskets extend above the body facing surface of the central portion
Inventor: MENARD MICHAEL J
IPC: A61L15/00
Filed: 1992-09-21
Abstract: Absorbent article for use in body perineal area, comprises an absorbent core (7) between liner (8) and backing sheet (9), portions (18,10) of both being brought together to form a leak preventing gasket flange (6) enclosed by a strip (48), pref. of flexible fabric (57) laminated to a foam layer (47). Pref. the article has wings for folding about an undergarment crotch, and has ends tensioned to curved form.
Patent NZ-260162-A (NZ)
Title: Elbow joint support; first and second bracing means rigidly connected to each other and to a patient's radius and ulna, respectively, with means for adjusting connections
Inventor: HOTCHKISS ROBERT N
IPC: A61B17/64
Filed: 1994-03-23
Abstract: A device for treating and preventing injuries and contractures of the elbow joint, particularly supination-pronation contractures and proximal radial head fractures. The device includes bracing sections for fixing the device to the radius and the ulna, and for permitting movement of the attached radius continually along a path which is adapted and adjusted to be aligned with the kinematic axis of the proximal radial- joint. <IMAGE>
Patent NZ-265188-A (NZ)
Title: Blanking unit for cutting out carton blanks: sheet material placed between top and bottom blanking frames
Inventor: PAUL MICHAEL
IPC: B26F1/38
Filed: 1994-04-05
Abstract: A blanking unit (10, 10a) for striking carton blanks from a sheet(s) of material comprises a top blanking frame (12) and a bottom blanking frame (14). The top blanking frame is vertically reciprocal relative to the bottom blanking frame so as to strike blanks from the sheet material when interposed between the frames. The bottom frame is formed with cutting edges (W1-W6; R1, R2) to shear through the sheet and the top frame is furnished with a number of profile plates (P1-P4) one for each blank (B1-B4) to be struck. Each profile plate conforms substantially to the general profile of the blank it is to strike and is adjustable in relation to that blank and relative to the remainder of the sheet.
Patent NZ-273806-A (NZ)
Title: Use of substituted thiazolidinedione derivatives in medicaments
Inventor: ANTONUCCI TAMMY
IPC: A61K31/41
Filed: 1994-09-09
Abstract: Treatment of impaired glucose tolerance, in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus comprises admin. of :(a)eg. a cpd. of formulae (I) or (II)(or a salt of these);(b) a cpd. of formula (IV) (or a cationic salt of (IV), or an acid addn. salt of (IV) when it contains a basic N atom);(c) a cpd. of formula (V) (or a cationic salt of (V), or an acid addn. salt of (V) when A or B is N);or (d) eg. a cpd. of formulae (VII) (or a tautomer, salt or solvate): R1, R2 = H or 1-5C alkyl; R3 = H, 1-6C aliphatic acyl,etc.;R4, R5 = H, 1-5C alkyl or 1-5C alkoxy; or R4+R5 = 1-4C alkylenedioxy; m = 1- 3; W = CH2 or CO etc.;Y, Z = O or NH; R11 = opt. substd. alkyl, alkoxy,etc.;L1, L2 = H or lower alkyl; or L1+L2 = alkylene;V = CH=CH, N=CH, CH=N or S; Za = H, 1-7C alkyl, 3-7C cycloalkyl,etc.;Z1 = H or 1-3C alkyl;q = 1- 3; A, B = CH or N, provided that they are not both N; X1 = S, O, SO2,etc.; s = 0-1; Y1 = CHR20 or R21; Z2 = CHR22, CH2CH2, CH=CH,etc.;R1y is not given; X2, X3 = H, Me, CF3, phenyl,etc. A2 = alkyl, opt. substd. aryl or opt. substd. aralkyl; A3 = a benzene ring with \~3 opt. substits.;R24 = H, alkyl, acyl, or opt. substd. aryl or aralkyl; or A2+R24 = 2-3C polymethylene (opt. substd. by alkyl or aryl, adjacent substits. together with the methylene carbon atoms opt. forming an opt. substd. phenylene gp.); R25, R26 = H; or R25+R26 = a bond; X4 = O or S; n = 2-6.
Patent NZ-294917-A (NZ)
Title: Anilinoquinazoline derivatives, preparative method and antiproliferative medicaments
Inventor: BROWN DEARG SUTHERLAND
IPC: A61P35/00
Filed: 1995-11-08
Abstract: PCT No. PCT/GB95/02606 Sec. 371 Date May 12, 1997 Sec. 102(e) Date May 12, 1997 PCT Filed Nov. 8, 1995 PCT Pub. No. WO96/15118 PCT Pub. Date May 23, 1996The invention concerns aniline derivatives of formula I    <IMAGE>  (I)  wherein m is 1, 2 or 3, n is 0, 1, 2 or 3, Q is phenyl or naphthyl or a 5- or 6-membered heteroaryl moiety containing 1, 2 or 3 heteroatoms selected from oxygen, nitrogen and sulfur, and X, R1 and R2 are defined in the claims; or pharmaceutical compositions containing them, and the methods of using the compounds as tyrosine kinase inhibitors and for the treatment of proliferative diseases such as cancer.
Patent NZ-312182-A (NZ)
Title: Apparatus for transporting submerged fluent cargo comprising at least one unit of two or more flexible containers close coupled side by side
Inventor: SAVAGE NICHOLAS MACEWAN
IPC: B63B35/28
Filed: 1996-07-08
Abstract: An apparatus and a method for transporting fluent cargoes through liquid are provided, the apparatus including one or more units arranged in substantially linear alignment, in which at least one of the units includes two or more non-internally reinforced containers close-coupled in a side-by-side manner.
Patent NZ-331191-A (NZ)
Title: 4-anilinoquinazoline derivatives and pharmaceutical compositions thereof
Inventor: THOMAS ANDREW PETER
IPC: A61K31/505
Filed: 1997-02-28
Abstract: The application relates to quinazoline derivatives of formula (I) where: R1 represents hydrogen or methoxy; R2 represents methoxy, ethoxy, 2-methoxyethoxy, 3-methoxypropoxy, 2-ethoxyethoxy, trifluoromethoxy, 2,2,2-trifluoroethoxy, 2-hydroxyethoxy, 3-hydroxypropoxy, 2-(N,N-dimethylamino)ethoxy, 3-(N,N-dimethylamino)propoxy, 2-morpholinoethoxy, 3-morpholinopropoxy, 4-morpholinobutoxy, 2-piperidinoethoxy, 3-piperidinopropoxy, 4-piperidinobutoxy, 2-(piperazin-1-yl)ethoxy, 3-(piperazin-1-yl)propoxy, 4-(piperazin-1-yl)butoxy, 2-(4-methylpiperazin-1-yl)ethoxy, 3-(4-methylpiperazin-1-yl)propoxy or 4-(4-methylpiperazin-1-yl)butoxy; the phenyl group bearing (R3)2 is selected from: 2-fluoro-5-hydroxyphenyl, 4-bromo-2-fluorophenyl, 2,4-difluorophenyl, 4-chloro-2-fluorophenyl, 2-fluoro-4-methylphenyl, 2-fluoro-4-methoxyphenyl, 4-bromo-3-hydroxyphenyl, 4-fluoro-3-hydroxyphenyl, 4-chloro-3-hydroxyphenyl, 3-hydroxy-4-methylphenyl, 3-hydroxy-4-methoxyphenyl and 4-cyano-2-fluorophenyl); and salts thereof, processes for their preparation and pharmaceutical compositions containing a compound of formula (I) or a pharmaceutically acceptable salt thereof as active ingredient. The compounds of formula (I) and the pharmaceutically acceptable salts thereof inhibit the effects of VEGF, a property of value in the treatment of a number of disease states including cancer and rheumatoid arthritis.
Patent NZ-335298-A (NZ)
Title: Casting roll for casting steel strip with steel stub shafts and copper tube having interconnected passageways for cooling water
Inventor: RUSSELL WAYNE
IPC: B22D11/06
Filed: 1999-04-20
Abstract: teel stub shafts 21, 22 are fixed to copper tube 20.  Water flow ducts are provided as that the roll assembly is "arbourless".
Patent NZ-336381-A (NZ)
Title: Formulation and method for treating neoplasms by inhalation
Inventor: PLACKE MICHAEL E
IPC: A61M11/00
Filed: 1997-12-30
Abstract: A formulation for treating neoplasms, such as cancer,  suitable for administration as a pharmaceutically effective amount of highly toxic composition by inhalation, comprises a non-encapsulated antineoplastic drug selected from doxorubicin, vincristine, vinorelbine and paclitaxel, in a defined dosage level.
Patent NZ-500061-A (NZ)
Title: Metallation of complexing agents with lanthanides and use as contrast agents
Inventor: HOMESTAD OLE MAGNE
IPC: A61K49/00
Filed: 1998-04-07
Abstract: A process for the preparation of a lanthanide complex by reaction of a lanthanide oxide with a complexing agent, ie DTPA-BMN, in an aqueous reaction medium.  The process comprises the steps of: a) determining the level of impurity in the lanthanide oxide, and b) mixing a lanthanide oxide from batches with different determined levels of impurity and/or including in the reaction medium a ore-determined quantity of oxalic acid, salt or derivative thereof. The reagents used in the metallation reaction contain oxalic acid or oxalate at a total level of at least 50ìg oxalic acid per gram lanthanide oxide.
Patent NZ-503958-A (NZ)
Title: Method for controlling the amount of ionised gases and/or particles over roads and streets
Inventor: JOHNSEN TORFINN
IPC: B03C3/02
Filed: 1998-09-17
Abstract: A method for controlling the amount of ionised gases and/or particles suspended in the air above roads, streets, open spaces or the like. The method involves establishing an electrical field between the top layer of a road, street, open space or the like, and the ionised gases and/or particles. By controlling the electrical field the amount of ionised gases and/or particles can be controlled. The electrical field is established by making at least the top layer of the surface concerned electrically conductive and connecting it to earth or to one pole of an electrical voltage source.
Patent NZ-504094-A (NZ)
Title: Modified starch prepared by cooking amphoteric or cationic starch with a polyacrylamide for use in the manufacture of paper
Inventor: MOFFETT ROBERT HARVEY
IPC: C08B31/00
Filed: 1998-10-23
Abstract: A modified starch prepared by heating at least one amphoteric starch, or cationic starch, with at least one nonionic, amphoteric or cationic polyacrylamide.  The starch, selected from corn, potato or waxy maize starch, must have a degree of substitution between 0.01 to 0.2.  The polyacrilamide must have a molecular weight of at least 500,000 and a degree of substitution between 1% and 80% by weight.  The starch is cooked at a temperature above 80 DEG C. in an aqueous solution having a pH above about 7.0 and containing an alkaline aluminium compound.  The weight ratio of starch to polyacrylamide is greater than about 5 to 1, for a time effective to modify the starch. The modified starch composites are useful in removing solids form an aqueous dispersion and as a retention aid in the manufacture of paper.
Patent NZ-505563-A (NZ)
Title: Ink composition comprising first and second optically variable pigments
Inventor: BLEIKOLM ANTON
IPC: C09D11/00
Filed: 1999-10-08
Abstract: This invention relates to an ink composition comprising two different types of optically variable pigments having a viewing angle dependent shift of colour.
Patent NZ-507459-A (NZ)
Title: Modifying the expression of the fsh beta gene by homologous recombination
Inventor: TRECO DOUGLAS A
IPC: A61K48/00
Filed: 1999-05-05
Abstract: A DNA construct that alters expression of an endogenous FSH-Beta (follicle stimulating hormone) gene in a mammalian cell upon integration into the genome of the cell via homologous recombination, the construct comprising at least 50 contiguous nucleotides of a targeting sequence and a transcriptional regulatory sequence. Also covered are cells transfected with said DNA construct, and a method of using said cells to produce FSH-Beta by culturing said cells under conditions that permit the expression and secretion of FSH-Beta.
Patent NZ-507964-A (NZ)
Title: Substituted sulphonyl cyanamides
Inventor: WEICHERT ANDREAS
IPC: C07D233/68
Filed: 1999-04-30
Abstract: Compounds of formula (I) that are inhibitors of the sodium-dependent bicarbonate/chloride ion exchanger which can be used as medicines for the prophylaxis or treatment of a wide range of diseases, for example the treatment and/or prophylaxis of myocardial infarction, angina pectoris, diseases caused by ischaemia, impaired respiration, cardiac ischaemia, ischaemia of the peripheral and central nervous system and stroke, ischaemia of the peripheral organs and limbs and diseases in which cell proliferation is a primary or secondary cause, in the treatment of shock, during surgical interventions and organ transplants or for preserving and storing transplants to be used in surgical interventions.
Patent NZ-514072-A (NZ)
Title: NAC1 - a plant gene encoding a transcription factor involved in cotyledon and lateral root development
Inventor: XIE QI
IPC: A01H5/00
Filed: 1999-02-11
Abstract: A nucleic acid with the sequence of SEQ ID NO:1 and a protein of sequence ID NO:2 encode a NAC family member, NAC1. Also described are transgenic plants comprising the nucleic acid and a method to grow genetically altered plants larger than a wild-type plant by over-expressing the NAC1 protein in the altered plant.
Patent NZ-514735-A (NZ)
Title: Polyalkene alcohol polyetheramines and use thereof in fuels and lubricants
Inventor: OPPENLANDER KNUT
IPC: C10L1/22
Filed: 2000-03-28
Abstract: A polyalkene alcohol polyetheramine the formula: R1-(CH2)n-(O-A)m-NR2R3 R1 is a polybutyl or polyisobutyl radical derived from isobutene and up to 20% by weight of n-butene and having a number average molecular weight of from 300 to 2500; R2 and R3 may be identical or different and are hydrogen, aliphatic or aromatic hydrocarbon radicals, primary or secondary, aromatic or aliphatic aminoalkylene radicals or polyaminoalkylene radicals, polyoxyalkylene radicals, heteroaryl or heterocyclyl radicals or, together with the nitrogen atom to which they are bonded, form a ring in which further heteroatoms may be present, the maximum number of carbon atoms in R2 and R3 together being 400; A is 1,2-propylene and/or ½-butylene; m is from 10 to 45; and n is 0 or 1.
Patent NZ-522871-A (NZ)
Title: Biocidal polymers based on guanidine salts
Inventor: SCHMIDT OSKAR J
IPC: C07C279/08
Filed: 2001-05-08
Abstract: Disclosed is a biocidal polymer guanidine derivative based on diamines which include two amino groups and oxyalkyl chains there between, characterised in that the guanidine derivatives are a product of a poycondensation of a guanidine acid addition salt with diamines which include polyalkyl chains between two amino groups. Polymers of the type disclosed are useful as disinfectants.
Patent NZ-525163-A (NZ)
Title: Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
Inventor: NAKAO KAZUNARI
IPC: C07D403/04
Filed: 2001-10-15
Abstract: Aryl or heteroaryl fused imidazole compounds of formula (I) are disclosed. The compounds have activity as prostaglandin E2 receptor agonists, and these are useful in the treatment or alleviation of pain and inflammation and other inflammation-associated disorders, such as arthritis.
Patent NZ-525298-A (NZ)
Title: Cationic latex terpolymers for sludge dewatering
Inventor: WHIPPLE WESLEY L
IPC: C08F220/56
Filed: 2001-12-19
Abstract: A cationic latex terpolymer prepared by polymerizing from about 1 to about 99.1 mole percent of one or more cationic monomers, from about 0.9 to about 5 mole percent of one or more hydroxyalkyl (meth)acrylates and from 0 to about 98.1 mole percent of one or more nonionic monomers is useful for dewatering sludge.
Patent NZ-525371-A (NZ)
Title: Oral formulation comprising an inhibitor compound of the ileal bile transport and an HMG Co-A reductase inhibitor
Inventor: STARKE INGEMAR
IPC: A61K45/00
Filed: 2001-10-12
Abstract: Disclosed is a pharmaceutical formulation for simultaneous, separate or sequential administration, comprising an IBAT inhibitor, an HMG Co-A reductase inhibitor and a bile acid binder, wherein the bile acid binder is in a dosage form with colon release of the bile acid binder. Also disclosed is the use of a bile acid binder in the manufacture of a medicament, wherein the bile acid binder is formulated for colon release, for use in prophylaxis or treatment of diarrhoea during therapy that comprises administration of an IBAT inhibitor and an HMG Co-A reductase inhibitor.
Patent NZ-525628-A (NZ)
Title: Gaming device and method
Inventor: WEISS STEVEN A
IPC: G07F17/32
Filed: 2001-10-12
Abstract: A gaming device comprises, in combination: - (a) A display; (b) A wagering means; and (c) A processor interposed between the display and the wagering means to initiate play of a primary game on the display upon activation of the wagering means. The display having at least one outcome that triggers a first bonus game and wherein the first bonus game has at least one outcome that triggers a second bonus game. The first bonus game comprises: - (i) A first exposed indicia; (ii) A plurality of unexposed cards assigned randomly chosen indicia, wherein one of the plurality of unexposed cards matches the first exposed indicia; (iii) A choice means for allowing a player to choose one of the plurality of unexposed cards; and (iv) A comparison means for determining whether the indicia assigned to the player chosen card matches the first exposed indicia.
Patent NZ-526795-A (NZ)
Title: Hardware component of an index-based weightless neural cortex using a single common index with a systematic expansion
Inventor: POK YANG MING
IPC: G06F15/18
Filed: 2000-11-30
Abstract: A neural network hardware component includes a random access memory (RAM); and an index-based weightless neural network with a columnar topography; wherein patterns of binary connections and values of output nodes' activities are stored in the RAM. A plurality of input components address a single index with a systematic expansion in the number of input components which is accommodated by incremental growth in the index. A method of processing information by pattern recognition using a neural network includes: (a) storing a plurality of output patterns to be recognised in a pattern index; (b) accepting an input pattern and dividing the input pattern into a plurality of components; (c) processing each component according to the pattern index to identify a recognised output pattern corresponding to the input pattern.
Patent NZ-529404-A (NZ)
Title: A cell therapy method for the treatment of tumours
Inventor: LETURCQ DIDIER J
IPC: A61K35/14
Filed: 2003-11-07
Abstract: Disclosed is the use of interferon-alfa that is capable of enhancing the expression of tumor antigen on the surface of a tumor and of autologous cytotoxic T lymphocytes with specificity for melanoma-associated target antigen in the preparation of a medicament for the treatment of melanoma in a subject in need thereof. The use wherein the medicament may further provide an effective amount of interferon-alfa of about 10 MU/m2 for subcutaneous administration per day to the subject consecutively from day 5 to day 1 prior to an inoculation of the subject with an effective amount of the autologous cytotoxic T lymphocytes, wherein; the cytotoxic T lymphocytes are obtained by a method comprising the steps of a) preparing a non-naturally occurring antigen-presenting cell line (nnAPC), wherein said nnAPC is capable of presenting up to about fifteen different epitopes associated with said melanoma simultaneously and where each epitope is a peptide of eight to ten amino acids in length; b) loading the nnAPC with up to about fifteen different epitopes associated with said melanoma; c) harvesting CD8+ cells from said subject; d) stimulating said CD8+cells with the epitope-loaded nnAPC cell line to obtain CD8+cells specific for the melanoma; e) growing the CD8+cells specific for the melanoma in media containing IL-2 and IL-7; f) mixing CD8+-depleted peripheral blood monocytes collected from said subject with each epitope used for nnAPC loading; g) irradiating said CD8+-depleted peripheral blood monocytes with gamma-radiation; h) isolating adherent CD8+-depleted peripheral blood monocytes; i) loading said adherent peripheral blood monocytes with each epitope used for nnAPC loading; j) restimulating said CD8+cells specific for the melanoma with the epitope loaded adherent peripheral blood monocytes; k) growing the restimulated CD8+cells specific for the melanoma in media containing IL-2 and IL-7; and l) expanding the restimulated CD8+cells specific for the melanoma by OKT3 antibody stimulation.
Patent NZ-529564-A (NZ)
Title: Methods and apparatus for producing and for applying labels
Inventor: BAUMLI PETER J
IPC: G09F3/02
Filed: 2002-05-01
Abstract: An apparatus for applying labels including hanging labels, in the form of a continuous web of material to containers is defined. The apparatus includes first and second reels on which the continuous web material is wound for application to containers by the apparatus. The apparatus includes an automatic splicing arrangement for feeding web material from a second reel after the first reel is exhausted. The labels are in the form of a continuous web of material and no separate support web is provided for the labels. The apparatus includes a pair of interchange rollers and a pair of associated guide means which merge to define a single guide means, and an indexing means disposed adjacent the point where the guide means merge. The interchange rollers are synchronously driven by a single drive means via a servo means or the like. The web of labels is made by printing on one or both sides of the web of material and plough-folding the web of material parallel to the longitudinal axis of the material to generate a succession of joined multi-layer labels or leaflets.
Patent NZ-530496-A (NZ)
Title: Method and device for coating pharmaceutical products
Inventor: FOLESTAD STAFFAN
IPC: A61J3/02
Filed: 2002-07-09
Abstract: A method for coating of a pharmaceutical product comprises the step of producing discrete droplets (7) of controlled size, shape and composition with at least one micro dispenser (1) and distributing droplets with controlled velocity and time of flight. Also, the method comprises the step of controlling the production frequency and modulation of the droplets. Further, the method comprises the step of controlling the flow rate, temperature and composition of the carrier gas and directing droplets towards particles subjected to coating. Also disclosed is a device for coating of a pharmaceutical product comprising a droplet producing unit and a droplet-directing unit (8). The droplet producing unit is a piezo- actuated micro dispenser for producing discrete droplets and controlling the size, shape and composition of said droplets.